ImmuCell Corporation (ICCC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.09B
EV to revenue ratio (TTM)
3.20
EV to ebitda
26.97
Financial Performance
Revenue (TTM)
$0.03B
Gross profit (TTM)
$0.01B
EBITDA
$0.01B
Profitability
Operating margin (TTM)
15.20%
Profit margin
2.57%
Return on assets (TTM)
6.25%
Return on equity (TTM)
2.57%
Per Share Metrics
Revenue per share (TTM)
$3.39
EPS
$0.07
Diluted EPS (TTM)
$0.07
Book value
$3.46
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
145.57
Trailing P/E
145.57
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
3.02
Price to book ratio (TTM)
3.01
Growth
Quarterly earnings growth (YoY)
11.50%
Quarterly revenue growth (YoY)
259.90%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
0.62